Figure 3From: Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancerKaplan-Meier survival plot for luminal BC training set using Ki-67LI and MS. (a) Breast cancer-specific survival (BCSS). (b) Metastasis-free survival at 10% and 50% Ki-67LI cut-off point. (c, d) BCSS and DMFS for mitosis-frequency scores.Back to article page